BCR and neoplasm: To determine whether the correlation between BCR diversity and survival is BCC-specific or represents a more generalizable phenomenon following checkpoint blockade, we aggregated data from published studies that include pre- and postimmunotherapy tumor sequencing and clinical outcomes.